Supervisor:

Roger Kouyos

PhD project:

Is Dolutegravir-Based Combination Antiretroviral Therapy Evolution Proof in Sub-Saharan Africa

Publication:

Loosli T, Hauser A, Josi J, [...] Günthard HF, Egger M,  Kouyos RD (2024).

Predicting emergent Dolutegravir resistance in South Africa: A modelling study (https://doi.org/10.1101/2024.07.20.24310740)

medRxiv, July 2024

Loosli T, Hossmann S, Ingle SM, Okhai H, Kusejko K, Mouton J, Bellecave P, van Sighem A, Stecher A, d’Arminio Monforte A, Gill MJ, Sabin CA, Maartens G, Günthard HF, Sterne JAC, Lessells R, Egger M, Kouyos R (2023).

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis (https://doi.org/10.1016/S2352-3018(23)00228-X)

The Lancet HIV, October 2023